E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/1/2014 in the Prospect News High Yield Daily.

New Issue: AmSurg prices upsized $1.1 billion 5 5/8% eight-year notes at par

By Paul A. Harris

Portland, Ore., July 1 – AmSurg Corp. priced an upsized $1.1 billion issue of eight-year senior notes (B3/B-/) at par to yield 5 5/8% on Tuesday, according to a syndicate source.

The deal was upsized from $880 million.

The yield printed at the tight end of yield talk in the 5¾% area and in line with earlier guidance in the mid-to-high 5% yield context.

Citigroup Global Markets Inc., SunTrust Robinson Humphrey Inc., BofA Merrill Lynch, Jefferies LLC and Wells Fargo Securities LLC were the joint bookrunners.

Proceeds, along with cash on hand, will be used to repay debt under the company’s revolver, to repay its senior secured notes due 2020 and to help fund AmSurg’s acquisition of Sheridan Healthcare. Additional proceeds, resulting from the upsizing of the notes offer, will be used to pay down the company’s term loan B.

AmSurg is a Nashville-based acquirer, developer and operator of ambulatory surgery centers.

Issuer:AmSurg Corp.
Amount:$1.1 billion, increased from $880 million
Maturity:July 15, 2022
Securities:Senior notes
Bookrunners:Citigroup Global Markets Inc., SunTrust Robinson Humphrey Inc., BofA Merrill Lynch, Jefferies LLC, Wells Fargo Securities LLC
Co-managers:Fifth Third Securities, J.P. Morgan Securities LLC, KeyBanc Capital Markets, Mitsubishi UFJ Securities, U.S. Bancorp Investments Inc., Barclays, BBVA Compass, Deutsche Bank Securities Inc., Goldman Sachs & Co., First Tennessee, Raymond James & Associates Inc.
Coupon:5 5/8%
Price:Par
Yield:5 5/8%
Spread:346 bps
First call:July 15, 2017 at 104.219
Equity clawback:35% at 105.625 until July 15, 2017
Change-of-control put:101%
Trade date:July 1
Settlement date:July 16
Ratings:Moody's: B3
Standard & Poor's: B-
Distribution:Rule 144A and Regulation S with registration rights
Price talk:5¾% area
Marketing:Roadshow

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.